1. Home
  2. ALLO vs RLGT Comparison

ALLO vs RLGT Comparison

Compare ALLO & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.38

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo Radiant Logistics Inc.

RLGT

Radiant Logistics Inc.

HOLD

Current Price

$6.52

Market Cap

291.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
RLGT
Founded
2017
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil Refining/Marketing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
291.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALLO
RLGT
Price
$1.38
$6.52
Analyst Decision
Buy
Strong Buy
Analyst Count
11
1
Target Price
$8.67
$8.00
AVG Volume (30 Days)
2.5M
158.6K
Earning Date
11-06-2025
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.35
EPS
N/A
0.31
Revenue
N/A
$925,786,000.00
Revenue This Year
N/A
$3.77
Revenue Next Year
$100.00
$3.51
P/E Ratio
N/A
$21.03
Revenue Growth
N/A
16.42
52 Week Low
$0.86
$5.44
52 Week High
$3.78
$7.94

Technical Indicators

Market Signals
Indicator
ALLO
RLGT
Relative Strength Index (RSI) 49.50 54.14
Support Level $1.32 $6.46
Resistance Level $1.52 $6.84
Average True Range (ATR) 0.10 0.16
MACD -0.02 -0.03
Stochastic Oscillator 28.57 40.04

Price Performance

Historical Comparison
ALLO
RLGT

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About RLGT Radiant Logistics Inc.

Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.

Share on Social Networks: